Eli Lilly and Company (ETR:LLY)
610.10
-7.30 (-1.18%)
Aug 22, 2025, 5:35 PM CET
Eli Lilly and Company Revenue
Eli Lilly and Company had revenue of $15.56B USD in the quarter ending June 30, 2025, with 37.64% growth. This brings the company's revenue in the last twelve months to $53.26B, up 36.83% year-over-year. In the year 2024, Eli Lilly and Company had annual revenue of $45.04B with 32.00% growth.
Revenue (ttm)
$53.26B
Revenue Growth
+36.83%
P/S Ratio
12.01
Revenue / Employee
$1.13M
Employees
47,000
Market Cap
544.79B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 45.04B | 10.92B | 32.00% |
Dec 31, 2023 | 34.12B | 5.58B | 19.56% |
Dec 31, 2022 | 28.54B | 223.00M | 0.79% |
Dec 31, 2021 | 28.32B | 3.78B | 15.40% |
Dec 31, 2020 | 24.54B | 2.22B | 9.95% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Siemens Healthineers AG | 23.38B |
Merck KGaA | 21.22B |
Bayer Aktiengesellschaft | 46.17B |
Fresenius SE & Co. KGaA | 22.28B |
Fresenius Medical Care AG | 19.52B |
Sartorius Aktiengesellschaft | 3.47B |
Fielmann Group AG | 2.33B |
Carl Zeiss Meditec AG | 2.18B |
Eli Lilly and Company News
- 1 day ago - $1000 Invested In Eli Lilly 15 Years Ago Would Be Worth This Much Today - Benzinga
- 1 day ago - Healthcare industry can handle and absorb tariffs, says Mizuho's Jared Holz - CNBC
- 1 day ago - Lilly to participate in Wells Fargo 20th Annual Healthcare Conference - PRNewsWire
- 1 day ago - J&J Commits $2 Billion To US Manufacturing Expansion Amid Threat Of Drug Tariffs - Benzinga
- 2 days ago - Eli Lilly and Company Investors: Company Investigated by the Portnoy Law Firm - GlobeNewsWire
- 2 days ago - Behind The Pick: Eli Lilly - Confidence In The Dip - Seeking Alpha
- 3 days ago - Healthcare Stocks Are Trading at Their Biggest Discount in 30 Years. Why a Turnaround May Have Already Started. - Barrons
- 3 days ago - Eli Lilly begins executive search as neuro chief Anne White retires - Seeking Alpha